Camlin Fine Sciences
Ticker > Company >

Camlin Fine Sciences share price

Camlin Fine Sciences Ltd.

NSE: CAMLINFINE BSE: 532834 SECTOR: Chemicals  83 K   134   31

201.55
-10.60 (-5.00%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 201.55

Today's Low

₹ 201.55

52 Week High

₹ 334.7

52 Week Low

₹ 93.59

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 3787.55 Cr.

Enterprise Value

₹ 4144.72 Cr.

No. of Shares

18.79 Cr.

P/E

0

P/B

4.52

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  44.57

CASH

₹ 84.65 Cr.

DEBT

₹ 441.82 Cr.

Promoter Holding

49.1 %

EPS (TTM)

₹  -3.9

Sales Growth

14.64%

ROE

-9.85 %

ROCE

-3.85%

Profit Growth

-48.5 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year14.64%
3 Year8.95%
5 Year8.86%

Profit Growth

1 Year-48.5%
3 Year-243.42%
5 Year-219.96%

ROE%

1 Year-9.85%
3 Year-3.23%
5 Year-0.48%

ROCE %

1 Year-3.85%
3 Year2.54%
5 Year4.45%

Debt/Equity

0.5209

Price to Cash Flow

173.23

Interest Cover Ratio

-0.6431

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 49.10 0.00
Mar 2025 49.10 10.84
Dec 2024 48.02 12.43
Sep 2024 48.02 12.43
Jun 2024 48.02 12.43
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 83.8794 days.

 Limitations

  • The company has shown a poor profit growth of -243.415825147434% for the Past 3 years.
  • The company has shown a poor revenue growth of 8.94824951980993% for the Past 3 years.
  • Company has a poor ROE of -3.23456666666667% over the past 3 years.
  • Company has a poor ROCE of 2.53826666666667% over the past 3 years
  • Company has low Interest coverage ratio of -0.6431.
  • Company has high debtor days of 186.5757.
  • The company is trading at a high EV/EBITDA of 45.6095.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 181.91 226.91 205.07 272.6 191.44
Total Expenditure 174.98 212.91 188.68 239.33 186.76
Operating Profit 6.93 14 16.4 33.27 4.68
Other Income 1.78 3.08 6.82 8.94 3.69
Interest 13.62 17.92 17.15 17.44 11.34
Depreciation 12.69 13.44 13.26 13.14 13.4
Exceptional Items 0 -96.27 0 0.26 0
Profit Before Tax -17.6 -110.54 -7.19 11.9 -16.38
Tax -3.92 -37.91 -1.57 -3.72 -5.7
Profit After Tax -13.68 -72.62 -5.63 15.62 -10.68
Adjusted EPS (Rs) -0.8 -4.24 -0.33 0.83 -0.57

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 600.05 685.51 789.44 773.26 886.49
Total Expenditure 534.46 606.25 657.07 740.58 807.33
Operating Profit 65.59 79.26 132.36 32.68 79.17
Other Income 7.6 19.89 29.47 20.85 21.05
Interest 38.38 36.39 62.39 61.85 75.12
Depreciation 19.28 26.68 32.82 49.39 52.53
Exceptional Items -0.5 0 0 -1.93 -96
Profit Before Tax 15.02 36.08 66.63 -59.63 -123.43
Tax 6.74 10.21 19.07 -8.24 -47.12
Net Profit 8.28 25.87 47.55 -51.39 -76.31
Adjusted EPS (Rs.) 0.63 1.61 2.96 -3 -4.06

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 12.75 15.7 15.71 16.75 18.79
Total Reserves 451.89 576.64 626.43 698.97 843.48
Borrowings 162.73 258.27 292.31 222.31 171.86
Other N/C liabilities 13.61 23.6 29.79 26.51 -27.2
Current liabilities 425.74 471.73 629.57 607.46 579.52
Total Liabilities 1066.71 1345.94 1593.81 1571.99 1586.45
Assets
Net Block 291.66 304.27 583.05 576.52 566.71
Capital WIP 18.44 206.69 28.18 31.26 9.1
Intangible WIP 0 0.18 0.18 0.18 0
Investments 73.56 81.78 81.8 79.87 63.53
Loans & Advances 22.54 28.78 22.91 22.91 14.81
Other N/C Assets 2.54 5.77 4.05 2.83 2.91
Current Assets 657.97 718.47 873.65 858.43 929.38
Total Assets 1066.71 1345.94 1593.81 1571.99 1586.45
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 15.02 36.08 66.63 -59.63 -123.43
Adjustment 65.49 54.71 75.96 144.5 176.76
Changes in Assets & Liabilities -44.12 -42.84 -116.67 15.52 -30.26
Tax Paid -10.37 -1.15 -7.39 -18.28 -1.2
Operating Cash Flow 26.02 46.8 18.52 82.1 21.86
Investing Cash Flow -88 -172.33 -114.73 -51.72 -87.66
Financing Cash Flow 80.05 128.92 78.39 -34.05 101.19
Net Cash Flow 18.08 3.39 -17.82 -3.67 35.39

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 48.02 48.02 48.02 49.10 49.10
anagha subhash dandekar 1.37 1.37 1.67 1.61 1.61
anand y pandit 0.01 0.01 0.01 0.01 0.01
anfima nv 7.99 7.99 7.99 9.03 9.03
ashish subhash dandekar 10.36 10.36 10.66 10.52 10.52
cafco consultants limited... 0.89 0.89 0.89 0.80 0.80
camart finance limited 3.18 3.18 3.18 2.83 2.83
infinity direct capital (... - - - - 4.93
infinity direct holdings 12.35 11.55 11.55 10.41 10.41
infinity holdings 6.37 5.97 5.97 6.34 6.34
infinity portfolio holdin... - 1.20 1.20 1.20 1.20
radha pandit 0.04 0.04 0.04 0.04 0.04
vibha agencies pvt ltd 1.56 1.56 1.56 1.39 1.39
infinity direct holdings ... 3.31 3.31 3.31 4.93 -
subhash digambar dandekar... 0.61 0.61 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 51.98 51.98 51.98 50.90 50.90
ajay upadhyaya 1.01 1.07 1.07 1.30 1.30
franklin india multi cap ... - - - - 1.21
icici prudential commodit... - - - - 1.04
investor education and pr... 0.58 - 0.58 0.52 0.52
jagdish n master 1.01 1.01 1.01 1.08 1.02
llp 0.27 0.37 0.37 0.28 0.32
nirmal vinod momaya 2.15 2.15 2.15 1.92 1.92
urjita j master 1.01 1.01 1.01 1.08 1.02
icici prudential smallcap... 4.11 4.11 3.38 2.69 -
investor education and pr... - 0.58 - - -

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit FITCH
Credit FITCH
Credit SMERA
Credit FITCH
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q3FY24
Concall Q3FY23
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY25
Presentation Q4FY24
Presentation Q4FY24
Presentation Q4FY21
Presentation Q4FY21
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY20
Presentation Q1FY24
Presentation Q1FY22
Presentation Q1FY21

Company News

Camlin Fine Sciences - Quaterly Results 8 Aug, 3:48 PM Camlin Fine Sciences - Quaterly Results 8 Aug, 3:48 PM Camlin Fine Sciences - Quaterly Results 8 Aug, 3:48 PM Camlin Fine Sciences informs about confirmation certificate 9 Jul, 11:50 AM Camlin Fine Sciences - Quaterly Results 23 May, 5:02 PM Camlin Fine Sciences - Quaterly Results 23 May, 5:02 PM Camlin Fine Sciences - Quaterly Results 23 May, 5:02 PM Camlin Fine Sciences informs about compliance certificate 8 Apr, 12:04 PM Camlin Fine Sciences informs about investor meet 12 Mar, 5:21 PM Camlin Fine Sciences - Quaterly Results 14 Feb, 4:01 PM Camlin Fine Sciences - Quaterly Results 14 Feb, 4:01 PM Camlin Fine Sciences - Quaterly Results 14 Feb, 4:01 PM Camlin Fine Sciences informs about newspaper publication 11 Feb, 4:51 PM Camlin Fine Sciences informs about appointment of independent director 5 Feb, 12:10 PM Camlin Fine Sciences informs about updates 1 Feb, 12:11 PM Camlin Fine Sciences informs about change in senior management 1 Feb, 10:57 AM Camlin Fine Sciences informs about receipt of an order 1 Feb, 10:30 AM Camlin Fine Sciences informs about change in name of RTA 3 Jan, 5:26 PM Camlin Fine Sciences informs about change in SMP 16 Dec, 5:16 PM Camlin Fine Sciences raises Rs 100 crore through NCDs 6 Dec, 9:30 AM Camlin Fine Sciences informs about loss of share certificate 4 Dec, 3:37 PM Camlin Fine Sciences gets nod for liquidation of CFS Pahang Asia 11 Nov, 4:25 PM Camlin Fine Sciences - Quaterly Results 11 Nov, 3:28 PM Camlin Fine Sciences - Quaterly Results 11 Nov, 3:28 PM Camlin Fine Sciences - Quaterly Results 11 Nov, 3:28 PM Camlin Fine Sciences informs about loss of share certificate 11 Oct, 5:22 PM Camlin Fine Sciences - Quaterly Results 12 Aug, 4:45 PM Camlin Fine Sciences - Quaterly Results 12 Aug, 4:45 PM Camlin Fine Sciences - Quaterly Results 12 Aug, 4:45 PM Camlin Fine Sciences informs about confirmation certificate 5 Jul, 11:19 AM Camlin Fine Sciences informs about press release 2 Jul, 2:37 PM Camlin Fine Sciences informs about closure of trading window 27 Jun, 2:34 PM Camlin Fine Sciences’ arm inks pact to acquire 100% stake in Vitafor Invest 12 Jun, 10:37 AM Camlin Fine Sciences - Quaterly Results 20 May, 7:44 PM Camlin Fine Sciences - Quaterly Results 20 May, 7:44 PM Camlin Fine Sciences informs about allotment of equity shares 28 Mar, 10:07 AM Camlin Fine Sciences informs about disclosure 20 Mar, 3:13 PM Camlin Fine Sciences informs about newspaper advertisements 12 Feb, 10:39 AM Camlin Fine Sciences - Quaterly Results 9 Feb, 4:16 PM Camlin Fine Sciences - Quaterly Results 9 Feb, 4:16 PM Camlin Fine Sciences - Quaterly Results 9 Feb, 4:16 PM Camlin Fine Sciences informs about trading window closure 26 Dec, 4:44 PM Camlin Fine Sciences informs about analyst meet 13 Dec, 3:38 PM Camlin Fine Sciences informs about issuance of duplicate share certificate 28 Nov, 2:54 PM Camlin Fine Sciences - Quaterly Results 7 Nov, 4:15 PM Camlin Fine Sciences - Quaterly Results 7 Nov, 4:15 PM Camlin Fine Sciences - Quaterly Results 7 Nov, 4:15 PM Camlin Fine Sciences informs about temporarily closure of plant 1 Nov, 2:59 PM Camlin Fine Sciences informs about confirmation certificate 9 Oct, 11:20 AM Camlin Fine Sciences informs about disclosure 16 Sep, 3:58 PM

Camlin Fine Sciences Stock Price Analysis and Quick Research Report. Is Camlin Fine Sciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Camlin Fine Sciences stock price today is Rs 204.15. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Camlin Fine Sciences . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Camlin Fine Sciences has a PE ratio of -52.3300522916026 which is low and comparatively undervalued .

  • Share Price: - The current share price of Camlin Fine Sciences is Rs 204.15. One can use valuation calculators of ticker to know if Camlin Fine Sciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Camlin Fine Sciences has ROA of -4.8322 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Camlin Fine Sciences has a Current ratio of 1.6037 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Camlin Fine Sciences has a ROE of -9.847 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Camlin Fine Sciences has a Debt to Equity ratio of 0.5209 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Camlin Fine Sciences has reported revenue growth of 14.6431 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Camlin Fine Sciences for the current financial year is 8.93026248537352 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Camlin Fine Sciences is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Camlin Fine Sciences is Rs -3.9012 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Camlin Fine Sciences in Ticker for free. Also, one can get the intrinsic value of Camlin Fine Sciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Camlin Fine Sciences

Camlin Fine Sciences Balance Sheet Analysis

Camlin Fine Sciences + Share Capital and Reserves Growth

From March 2020 to March 2024, Camlin Fine Sciences has shown a consistent increase in Share Capital and Total Reserves. Share capital grew from ?12.13 Cr in Mar 2020 to ?16.75 Cr in Mar 2024. Total Reserves escalated significantly from ?364.68 Cr in 2020 to ?698.97 Cr in 2024, indicating a robust accumulation of retained earnings and possibly a healthy reinvestment back into the company.

Camlin Fine Sciences + Debt Management

The company’s borrowings peaked in March 2022 at ?258.27 Cr but notably decreased to ?222.31 Cr by March 2024. This reduction in borrowings suggests an improvement in debt management and a potential decrease in financial risk for the company.

Camlin Fine Sciences + Asset Growth

Camlin Fine Sciences experienced substantial growth in its Net Block, rising dramatically from ?93.57 Cr in March 2020 to ?576.52 Cr in March 2024, primarily reflecting significant capital investments. Current Assets saw growth from ?511.17 Cr to ?858.43 Cr during the same period, highlighting an improvement in liquidity positions.

Other Key Financial Elements

Investments and Loans & Advances have remained relatively stable, providing a balanced financial strategy in its assets distribution.

This data is an analysis for the Standalone Balance Sheet of Camlin Fine Sciences.

Camlin Fine Sciences operates within the chemical sector, which is crucial for investors considering sector-based diversification in their portfolios.

Read More
X